InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 2A 18 Dec 2023 7:10PM $0.110 $0.230 risen by 109.09%
- PharmAust Launches Interactive Investor Hub 18 Dec 2023 9:22AM $0.110 $0.230 risen by 109.09%
- Cleansing Notice 18 Dec 2023 9:21AM $0.110 $0.230 risen by 109.09%
- Application for quotation of securities - PAA 18 Dec 2023 9:20AM $0.110 $0.230 risen by 109.09%
- Update - Proposed issue of securities - PAA 18 Dec 2023 9:15AM $0.110 $0.230 risen by 109.09%
- 93% take up in Options Offer 15 Dec 2023 8:55AM $0.110 $0.230 risen by 109.09%
- Update - Proposed issue of securities - PAA 14 Dec 2023 12:20PM $0.110 $0.230 risen by 109.09%
- Proposed issue of securities - PAA 13 Dec 2023 9:59AM $0.105 $0.230 risen by 119.05%
- PharmAust Raises $3.5 Million at a Premium 13 Dec 2023 9:59AM $0.105 $0.230 risen by 119.05%
- Trading Halt 11 Dec 2023 9:52AM $0.105 $0.230 risen by 119.05%
- New Hires & Attendance at International MND Symposium 6 Dec 2023 8:18AM $0.100 $0.230 risen by 130%
- PAA completes Phase 1 and files for Orphan Drug Designation 1 Dec 2023 9:37AM $0.093 $0.230 risen by 147.31%
- Prospectus & Target Market Determination 21 Nov 2023 2:48PM $0.084 $0.230 risen by 173.81%
- Results of Annual General Meeting 20 Nov 2023 3:45PM $0.080 $0.230 risen by 187.50%
- Appendix 3Y x 4 6 Nov 2023 3:59PM $0.078 $0.230 risen by 194.87%
- PharmAust to present at Emerging ASX Gems Conference 2 Nov 2023 11:19AM $0.076 $0.230 risen by 202.63%
- Appendix 4C and Quarterly Update 30 Oct 2023 10:01AM $0.071 $0.230 risen by 223.94%
- Application for quotation of securities - PAA 27 Oct 2023 6:14PM $0.071 $0.230 risen by 223.94%
- Notice of Annual General Meeting & Proxy Form 19 Oct 2023 2:44PM $0.075 $0.230 risen by 206.67%
- Proposed issue of securities - PAA 18 Oct 2023 10:22AM $0.075 $0.230 risen by 206.67%
- Options Offer to Existing Listed Option Holders 18 Oct 2023 10:21AM $0.075 $0.230 risen by 206.67%
- Final MND Patient in Cohort 4 Successfully Completes Dosing 13 Oct 2023 8:40AM $0.075 $0.230 risen by 208.72%
- Canine Oncology Data Supports Progression to Registration 9 Oct 2023 9:43AM $0.081 $0.230 risen by 183.95%
- Trading Halt 6 Oct 2023 8:57AM $0.081 $0.230 risen by 183.95%
- Clarification to notification of expiry of quoted options 2 Oct 2023 6:22PM $0.080 $0.230 risen by 187.50%

126 - 150 of 796 results

Page 6 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.